𝔖 Bobbio Scriptorium
✦   LIBER   ✦

How can we improve the design and endpoints of symptomatic and disease modifying clinical trials in Parkinson’s disease?

✍ Scribed by C.E. Clarke

Book ID
119192877
Publisher
Elsevier
Year
2012
Tongue
English
Weight
331 KB
Volume
2
Category
Article
ISSN
2210-5336

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

American association for the study of li
American association for the study of liver diseases endpoints conference: Design and endpoints for clinical trials in primary biliary cirrhosis
✍ Marina G. Silveira; Elizabeth M. Brunt; Jenny Heathcote; Gregory J. Gores; Keith 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 1 views

A group of multidisciplinary experts on primary biliary cirrhosis (PBC) and its complications convened on May 31, 2009, under the aegis of the American Association for the Study of Liver Diseases (AASLD) in order to identify the most appropriate design and endpoints for clinical trials of PBC based

How do we improve the quality of clinica
How do we improve the quality of clinical trials in Japan? The role of the medical doctor
✍ Toshiki Mano; Fumiko Alaya 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 2 views

## How Do We Improve the Quality of Clinical Trials in Japan? The Role of the Medical Doctor In recent years, a lot of focus has been on the quality of clinical trials in Japan. The implementation of the new Good Clinical Practice (GCP), harmonized with international standards, has prompted drug c